Proteogenomics drug development workflows are closing the gap between what genomic data predicts and what proteins actually do, but most labs have not yet built the infrastructure to exploit these ...

A combination of genetic testing approaches enabled researchers in Spain to more accurately characterize complex genetic changes that may help explain differences in disease severity in spinal ...

A recent class-action lawsuit alleges that David Protein misrepresented the calorie and fat contents in its popular protein bars, a challenge for a company known for catering to health-conscious ...

Direct cardiac reprogramming represents a promising strategy to regenerate damaged myocardium by converting cardiac fibroblasts into induced cardiomyocytes (iCMs). Transient delivery of a ...

Once exclusively a treatment for diabetes, GLP-1 medications have gone mainstream — forcing restaurants to adjust to changing appetites and nutrition needs. As GLP-1 medications normalize smaller ...

After a Consumer Reports investigation revealed that some popular protein powders and shakes contained troubling levels of lead, many readers wrote in with a simple question: What does this mean for ...

Protein quantification is critical in biologics research and development. However, current methods such as ELISA, BLI, and SPR have complex workflows and can struggle with crude samples or early-stage ...

insights from industryDr. Ruizhi WangFounder and CEOAbselion In this interview, News Medical-Life Sciences speaks with Dr. Ruizhi Wang, Founder and CEO of Abselion, about simplifying the ...

The company highlights how its technology powers large-scale proteomic perturbation studies, unveiling Perturb-PBMC, a 1.4 million–protein PBMC dataset available in the Nomic Portal ...

MONTREAL--(BUSINESS WIRE)--Nomic Bio (“Nomic”) today announced publication of its core nELISA® technology in Nature Methods, detailing a high‑throughput, high‑plex immunoassay platform that side-steps ...